Efficacy Study of Intramuscular or Intracoronary Injection of Autologous Bone Marrow Cells to Treat Scarred Myocardium

Myocardial Infarct Clinical Trial

Official title:
Efficacy of the Mode of Delivery of Autologous Bone Marrow Cells Into Heart Scar Muscle for the Recovery of Contractile Function

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether the administration of patient's own bone marrow cells into scar areas of the heart, can improve the contractile function of these areas.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00560742
Study type	Interventional
Source	University Hospitals, Leicester
Contact
Status	Completed
Phase	Phase 2
Start date	November 2002
Completion date	July 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01179776` - Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)	Phase 1/Phase 2
Terminated	`NCT00237471` - Impact of Tight Glycaemic Control in Acute Myocardial Infarction	Phase 4
Active, not recruiting	`NCT02967965` - CARdioprotection in Myocardial Infarction
Completed	`NCT01264783` - Safety and Tolerability of RNS60 Given by IV to Healthy Subjects	Phase 1
Completed	`NCT01033617` - IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG	N/A
Completed	`NCT00338156` - Observational Study of the Remodelling Process Following Myocardial Infarct	N/A